October 21, 2016 5:44 AM ET


Company Overview of Pearl Therapeutics Inc.

Company Overview

Pearl Therapeutics Inc. develops and commercializes dual and triple combination products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease, asthma, and rhinosinusitis worldwide. The company focuses on developing inhaled therapies. It offers a fixed-dose combination bronchodilator; PT001 (glycopyrronium) and PT005 (formoterol fumarate), which are monotherapy components; and PT003, a fixed-dose combination of glycopyrronium, a long-acting muscarinic antagonist, as well as formoterol fumarate, a long acting ß2-agonist for the treatment of chronic obstructive pulmonary disease. The company was founded in 2006 and is based in Redwood City, California. As o...

200 Cardinal Way

Redwood City, CA 94063

United States

Founded in 2006





Key Executives for Pearl Therapeutics Inc.

Chief Executive Officer, President and Director
Age: 55
Executive Chairman
Age: 71
Co-Founder and Chief Scientific Officer
Chief Executive Officer of Vatera Holdings LLC and Chief Investment Officer of Vatera Holdings LLC
Age: 45
Chief Medical Officer and Executive Vice President of Clinical Development & Medical Affairs
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pearl Therapeutics Inc., please visit www.pearltherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.